Rituximab versus Mycophenolate Mofetil in Patients with Pemphigus Vulgaris

Victoria P. Werth, Pascal Joly, Daniel Mimouni, Emanual Maverakis, Frédéric Caux, Patricia Lehane, Liudmila Gearhart, Audrey Kapre, Pooneh Pordeli, Diana M. Chen

doi:10.1056/nejmoa2028564

Rituximab versus Mycophenolate Mofetil in Patients with Pemphigus Vulgaris

DOI Web Site 被引用文献3件

Victoria P. Werth

From the Perelman School of Medicine, University of Pennsylvania, and the Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia (V.P.W.); the Department of Dermatology, Rouen University Hospital and INSERM 1234, Normandie Université, Rouen (P.J.), and the Department of Dermatology, Groupe Hospitalier Paris Seine-Saint-Denis, Assistance Publique–Hôpitaux de Paris and INSERM Unité Mixte de Recherche 1125, Bobigny (F.C.) — all in France; the Sackler School of Medicine, Tel Aviv...
Pascal Joly

From the Perelman School of Medicine, University of Pennsylvania, and the Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia (V.P.W.); the Department of Dermatology, Rouen University Hospital and INSERM 1234, Normandie Université, Rouen (P.J.), and the Department of Dermatology, Groupe Hospitalier Paris Seine-Saint-Denis, Assistance Publique–Hôpitaux de Paris and INSERM Unité Mixte de Recherche 1125, Bobigny (F.C.) — all in France; the Sackler School of Medicine, Tel Aviv...
Daniel Mimouni

From the Perelman School of Medicine, University of Pennsylvania, and the Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia (V.P.W.); the Department of Dermatology, Rouen University Hospital and INSERM 1234, Normandie Université, Rouen (P.J.), and the Department of Dermatology, Groupe Hospitalier Paris Seine-Saint-Denis, Assistance Publique–Hôpitaux de Paris and INSERM Unité Mixte de Recherche 1125, Bobigny (F.C.) — all in France; the Sackler School of Medicine, Tel Aviv...
Emanual Maverakis

From the Perelman School of Medicine, University of Pennsylvania, and the Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia (V.P.W.); the Department of Dermatology, Rouen University Hospital and INSERM 1234, Normandie Université, Rouen (P.J.), and the Department of Dermatology, Groupe Hospitalier Paris Seine-Saint-Denis, Assistance Publique–Hôpitaux de Paris and INSERM Unité Mixte de Recherche 1125, Bobigny (F.C.) — all in France; the Sackler School of Medicine, Tel Aviv...
Frédéric Caux

From the Perelman School of Medicine, University of Pennsylvania, and the Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia (V.P.W.); the Department of Dermatology, Rouen University Hospital and INSERM 1234, Normandie Université, Rouen (P.J.), and the Department of Dermatology, Groupe Hospitalier Paris Seine-Saint-Denis, Assistance Publique–Hôpitaux de Paris and INSERM Unité Mixte de Recherche 1125, Bobigny (F.C.) — all in France; the Sackler School of Medicine, Tel Aviv...
Patricia Lehane

From the Perelman School of Medicine, University of Pennsylvania, and the Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia (V.P.W.); the Department of Dermatology, Rouen University Hospital and INSERM 1234, Normandie Université, Rouen (P.J.), and the Department of Dermatology, Groupe Hospitalier Paris Seine-Saint-Denis, Assistance Publique–Hôpitaux de Paris and INSERM Unité Mixte de Recherche 1125, Bobigny (F.C.) — all in France; the Sackler School of Medicine, Tel Aviv...
Liudmila Gearhart

From the Perelman School of Medicine, University of Pennsylvania, and the Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia (V.P.W.); the Department of Dermatology, Rouen University Hospital and INSERM 1234, Normandie Université, Rouen (P.J.), and the Department of Dermatology, Groupe Hospitalier Paris Seine-Saint-Denis, Assistance Publique–Hôpitaux de Paris and INSERM Unité Mixte de Recherche 1125, Bobigny (F.C.) — all in France; the Sackler School of Medicine, Tel Aviv...
Audrey Kapre

From the Perelman School of Medicine, University of Pennsylvania, and the Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia (V.P.W.); the Department of Dermatology, Rouen University Hospital and INSERM 1234, Normandie Université, Rouen (P.J.), and the Department of Dermatology, Groupe Hospitalier Paris Seine-Saint-Denis, Assistance Publique–Hôpitaux de Paris and INSERM Unité Mixte de Recherche 1125, Bobigny (F.C.) — all in France; the Sackler School of Medicine, Tel Aviv...
Pooneh Pordeli

From the Perelman School of Medicine, University of Pennsylvania, and the Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia (V.P.W.); the Department of Dermatology, Rouen University Hospital and INSERM 1234, Normandie Université, Rouen (P.J.), and the Department of Dermatology, Groupe Hospitalier Paris Seine-Saint-Denis, Assistance Publique–Hôpitaux de Paris and INSERM Unité Mixte de Recherche 1125, Bobigny (F.C.) — all in France; the Sackler School of Medicine, Tel Aviv...
Diana M. Chen

From the Perelman School of Medicine, University of Pennsylvania, and the Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia (V.P.W.); the Department of Dermatology, Rouen University Hospital and INSERM 1234, Normandie Université, Rouen (P.J.), and the Department of Dermatology, Groupe Hospitalier Paris Seine-Saint-Denis, Assistance Publique–Hôpitaux de Paris and INSERM Unité Mixte de Recherche 1125, Bobigny (F.C.) — all in France; the Sackler School of Medicine, Tel Aviv...